Overview
Abu Dhabi Global Health Week convened healthcare leaders, policymakers, and disruptors from around the world to shape the future of healthcare. The event showcased the latest technologies aimed at paving the way toward longevity and redefining health and well-being.
The 2025 conference focused on health system resilience and sustainability, longevity and precision health, digital health and artificial intelligence (AI), and investment in life sciences.
Oliver Wyman was proud to be a knowledge partner for the 2025 edition.
Our Session
April 15, 9:40 a.m.—10:05 a.m. GST
Life Sciences Investment — What Type Of Business Environment Accelerates Investment
A strong business environment is essential for fostering innovation and investment in life sciences. Effective policies, regulatory frameworks, and financial incentives play a crucial role in attracting research and development, while demographic factors such as population health trends and market demand further shape the industry's growth. In an increasingly competitive global landscape, regions that strategically align these elements can position themselves as leading life sciences hubs. The session covered how Abu Dhabi stands out with its rapidly growing life sciences cluster, leveraging targeted investments, advances infrastructure, and supportive policies to drive innovation and international collaboration.
Moderator: Sumit Sharma, partner, Oliver Wyman
Speakers: Isabel Afonso, CEO, Arcera, UAE; Dr. Bettina Ernst, vice president of Swiss Biotech Association (VP SBA), Switzerland; Dr. Peter Kash, Ed.D/MBA, co-founder of Targlmmune Therapeutics and iOncologi and chairman of Camelot BioCapital, USA; Elodie Robin-Guillerm, head of global clusters, Abu Dhabi Investment Office, UAE; Alessandro Borgogna, advisor to the director general, Abu Dhabi Investment Office (ADIO)
Meet The Team
